New X-Ray tool could simplify heart calcium detection

NCT ID NCT07417150

First seen Feb 24, 2026 · Last updated Jun 19, 2026 · Updated 14 times

Summary

This study tested a new X-ray-based imaging tool called 3DStent against the standard IVUS method for measuring calcium buildup in heart arteries. Thirty adults with coronary calcification underwent both imaging techniques during angioplasty. The goal was to see if 3DStent could accurately measure the extent of calcium, which could help doctors decide on the best treatment without needing an extra invasive procedure.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY CALCIFICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Hôpital Privé Claude Galien, Institut Cardiovasculaire Paris Sud

    Quincy-sous-Sénart, 91480, France

  • Hôpital Privé Jacques Cartier, Institut Cardiovasculaire Paris Sud

    Massy, 91300, France

  • Hôpital Privé d'Antony, Institut Cardiovasculaire Paris Sud

    Antony, 92160, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could give doctors a simpler, less invasive way to measure calcium in heart arteries, potentially improving treatment planning for patients with coronary artery disease.

What could go wrong

This is a small pilot study with only 30 participants, so results may not apply to everyone. The 3DStent method is being tested off-label and may not prove as accurate as IVUS in real-world use.

Conditions

The condition(s) this trial relates to.

coronary atherosclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.